A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L)-Reference-Cited by-同舟云学术

A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L)

Published:2023-12 Issue:12 Volume:4 Page:100587
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Wakuda Kazushige^ORCID,Yamaguchi Hiroyuki,Kenmotsu Hirotsugu,Fukuda Minoru,Ito Kentaro,Tsuchiya-Kawano Yuko,Tanaka Kentaro,Harada Taishi,Nakatani Yuki,Miura Satoru,Yokoyama Toshihide,Nakamura Tomomi,Izumi Miiru,Nakamura Atsushi,Ikeda Satoshi,Takayama Koichi,Yoshimura Kenichi,Nakagawa Kazuhiko,Yamamoto Nobuyuki,Sugio Kenji

Funder

AstraZeneca KK

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib;Omuro;Cancer,2005

2. Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer;Lee;Cancer,2010

3. Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations;Iuchi;Int J Clin Oncol,2015

4. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial;Andrews;Lancet,2004

5. Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1–3 brain metastases; poststratified by the graded prognostic assessment (GPA);Sperduto;Int J Radiat Oncol Biol Phys,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complete response in a lung adenocarcinoma with pleural metastases initially treated with gefitinib and switched to osimertinib after cerebral oligo-progression with unknown T790M mutation: a case report and review of literature;Journal of Medical Case Reports;2024-08-08